ArticleJournal of thoracic disease2017

The future of achalasia therapy: expanding the minimally invasive armamentarium and risk of secondary gastroesophageal reflux.

Kelsey F Angell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.